Standout Papers

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthr... 2013 2026 2017 2021 538
  1. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial (2013)
    Gerd R Burmester, Ricardo Blanco et al. The Lancet
  2. Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors (2017)
    Dafna D. Gladman, William F. C. Rigby et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 116 standout
Sub-graph 1 of 17

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
A break in mitochondrial endosymbiosis as a basis for inflammatory diseases
2024 StandoutNature
3 intermediate papers

Works of Ricardo Blanco being referenced

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
2013 Standout
Systemic Lupus Erythematosus in Northwestern Spain
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
Ricardo Blanco 5832 2838 2620 454 9.8k
Zahir Amoura 7119 3092 6111 416 16.9k
Jean‐Charles Piette 5862 2350 2800 197 13.7k
David Saadoun 4298 3795 3006 352 13.3k
Gerard Espinosa 5172 1120 1698 327 8.4k
Elisabeth Brouwer 4459 4315 2434 239 9.1k
Manuel Ramos‐Casals 7577 1928 4035 253 17.5k
T. Papo 2000 1473 1526 240 6.2k
María C. Cid 5130 7005 2144 200 11.0k
Leendert A. van Es 2504 4606 4027 232 11.8k
Graham R.V. Hughes 13332 2675 4282 258 17.9k

All Works

Loading papers...

Rankless by CCL
2026